相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles, an antibody conjugate with potent and selective anti-hepatocellular carcinoma activity
Yin Xiangbao et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Progress of drug-loaded polymeric micelles into clinical studies
Horacio Cabral et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody
Jingjing Yang et al.
ONCOTARGETS AND THERAPY (2014)
ScFv-Decorated PEG-PLA-Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast Cancer
Shuang Dou et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris
Lin Wan et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies
Yicheng Mao et al.
CLINICAL CANCER RESEARCH (2013)
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Susan O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Neil Senzer et al.
MOLECULAR THERAPY (2013)
Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists
Gopalakrishna Pillai et al.
SAGE OPEN MEDICINE (2013)
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
Philippe P. Monnier et al.
ANTIBODIES (2013)
Dendrimers in biomedical applications-reflections on the field
Soenke Sevenson et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
scFv Antibody: Principles and Clinical Application
Zuhaida Asra Ahmad et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
Nanoparticles as drug delivery systems
Agnieszka Z. Wilczewska et al.
PHARMACOLOGICAL REPORTS (2012)
Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
Ruei-Min Lu et al.
BIOMATERIALS (2011)
Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone
Xiliang Luo et al.
BIOMATERIALS (2011)
A Note From History: Landmarks in History of Cancer, Part 1
Steven I. Haidu
CANCER (2011)
Cyclodextrin-based gene delivery systems
Carmen Ortiz Mellet et al.
CHEMICAL SOCIETY REVIEWS (2011)
Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure
A. Kovacevic et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin
Cristiane dos Santos Giuberti et al.
JOURNAL OF LIPOSOME RESEARCH (2011)
Controlled Drug Delivery System Based on Ordered Mesoporous Silica Matrices of Captopril as Angiotensin-Converting Enzyme Inhibitor Drug
R. F. Popovici et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Advancement in carbon nanotubes: basics, biomedical applications and toxicity
Sarwar Beg et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Cancer theranostics: the rise of targeted magnetic nanoparticles
Adam J. Cole et al.
TRENDS IN BIOTECHNOLOGY (2011)
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Omid Veiseh et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-κB pathways
Xin Liu et al.
BIOMATERIALS (2010)
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B. Silverman et al.
BLOOD (2010)
Characterization of and biomolecule immobilization on the biocompatible multi-walled carbon nanotubes generated by functionalization with polyamidoamine dendrimers
Baoling Zhang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
被撤回的出版物: Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress (Retracted article. See vol. 17, pg. 1459, 2022)
Saba Naqvi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2010)
Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery
Zhenhuan Li et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2010)
Synthesis and characterization of ultramicroporous silica xerogels
Jesus C. Echeverria et al.
JOURNAL OF NON-CRYSTALLINE SOLIDS (2010)
Silica-Encapsulated Efficient and Stable Si Quantum Dots with High Biocompatibility
G. Amato
NANOSCALE RESEARCH LETTERS (2010)
Nanoparticle-assisted combination therapies for effective cancer treatment
Che-Ming Jack Hu et al.
THERAPEUTIC DELIVERY (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Kyeongsoon Park et al.
ADVANCED FUNCTIONAL MATERIALS (2009)
Adsorption of the Pt-II Anticancer Drug Carboplatin by Mesoporous Silica
Anthony J. Di Pasqua et al.
CHEMISTRY & BIODIVERSITY (2009)
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications
Venkata K. Yellepeddi et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening-A Report From the American Society of Clinical Oncology
Nicholas J. Petrelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Toxicity of amorphous silica nanoparticles in mouse keratinocytes
Kyung O. Yu et al.
JOURNAL OF NANOPARTICLE RESEARCH (2009)
Sustained In Vivo Inhibition of Protein Domains Using Single-Chain Fv Recombinant Antibodies and Its Application to Dissect RGMa Activity on Axonal Outgrowth
Nardos G. Tassew et al.
JOURNAL OF NEUROSCIENCE (2009)
Wet sol-gel silica matrices as delivery devices for phenytoin
Alexandra Fidalgo et al.
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY (2009)
MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/Il study in gastro-esophageal adenocarcinoma, with pharmacokinetics
Neil N. Senzer et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging
Lily Yang et al.
SMALL (2009)
Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro
Eun-Jung Park et al.
TOXICOLOGY LETTERS (2009)
Enhancement of In Vivo Anticancer Effects of Cisplatin by Incorporation Inside Single-Wall Carbon Nanohorns
Kumiko Ajima et al.
ACS NANO (2008)
Polymer-drug conjugates: Recent development in clinical oncology
Chun Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Magnetic nanoparticles in MR imaging and drug delivery
Conroy Sun et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Folate and Folate-PEG-PAMAM Dendrimers: Synthesis, Characterization, and Targeted Anticancer Drug Delivery Potential in Tumor Bearing Mice
Prateek Singh et al.
BIOCONJUGATE CHEMISTRY (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Biofunctionalized targeted nanoparticles for therapeutic applications
Andrew Z. Wang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Antibody-modified liposomes for cancer chemotherapy
Vladimir Torchilin
EXPERT OPINION ON DRUG DELIVERY (2008)
Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy
Tarsuya Murakami et al.
NANOMEDICINE (2008)
Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues
Marianna Foldvari et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand et al.
PHARMACEUTICAL RESEARCH (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Impact of single-chain fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells
Yu Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Magnetic nanoparticles for drug delivery
Manuel Arruebo et al.
NANO TODAY (2007)
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
Dan Peer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nanotherapeutics for enhancing thermal therapy of cancer
Rachana Visaria et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2007)
In vitro toxicity of silica nanoparticles in human lung cancer cells
Weisheng Lin et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Synthetic therapeutic antibodies
Sachdev S. Sidhu et al.
NATURE CHEMICAL BIOLOGY (2006)
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging
Marianne Manchester et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
Anne des Rieux et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Nanotechnology: Intelligent design to treat complex disease
Patrick Couvreur et al.
PHARMACEUTICAL RESEARCH (2006)
Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy
Cornelia Marty et al.
CANCER LETTERS (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Targeted nanoparticles for detecting and treating cancer
Christopher J. Sunderland et al.
DRUG DEVELOPMENT RESEARCH (2006)
Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-Lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis
DF Nellis et al.
BIOTECHNOLOGY PROGRESS (2005)
Characterization of dendrimers
AM Caminade et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex
AK Patri et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Development and regulation of monoclonal antibody products: Challenges and opportunities
WC Weinberg et al.
CANCER AND METASTASIS REVIEWS (2005)
Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
DB Shenoy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, and fullerene
G Jia et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2005)
Cancer nanotechnology: Opportunities and challenges
M Ferrari
NATURE REVIEWS CANCER (2005)
Quantitative immuno-positron emission tomography imaging oil HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody
MK Robinson et al.
CANCER RESEARCH (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Folate-targeted chemotherapy
CP Leamon et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Solid lipid nanoparticles for parenteral drug delivery
SA Wissing et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Targeted therapies for cancer 2004
JS Ross et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Preclinical safety testing of biotechnology-derived pharmaceuticals - Understanding the issues and addressing the challenges
FR Brennan et al.
MOLECULAR BIOTECHNOLOGY (2004)
An overview of targeted treatments in cancer
R Abou-Jawde et al.
CLINICAL THERAPEUTICS (2003)
Renaissance of cancer therapeutic antibodies
MJ Glennie et al.
DRUG DISCOVERY TODAY (2003)
Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes
JW Yockman et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker
T Suzawa et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs
G Pavlinkova et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Improving the efficacy of antibody-based cancer therapies
P Carter
NATURE REVIEWS CANCER (2001)
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
D Douer et al.
BLOOD (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
分享论文
